Rich Verde

Director, Launch Excellence, Uro-Oncology Ferring Pharmaceuticals

Rich Verde is a Senior Commercial Leader at Ferring Pharmaceuticals who helped build the commercial organization and operating model behind what is now the fourth best-selling gene therapy in the United States. Since approval, he has helped shape the strategy, structure, and cross-functional execution that grew the business from a small core team into a successful oncology launch generating several hundred million dollars in sales and growing. His career has spanned sales, marketing, commercial operations, strategy, and launch excellence. He has built teams, developed talent, led brands, executed complex launches, and most importantly, had a lot of fun doing it.

Pharma Launch Excellence Summit Conference Day 1: Wednesday September 30

9:00 AM Morning Presentation / Case Study: "Starting at the Finish Line": When FDA Approval Is the Starting Point

Most launches spend years preparing for approval. This one started there. With no runway, a small initial team, and no fully established commercial infrastructure, the challenge was not simply bringing a groundbreaking gene therapy to market. It was building the team, operating model and go-to-market strategy between approval and first commercial treatment in record time.

Drawing on a journey from a team of two to a full commercial organization with significant annual sales, Rich will share practical lessons on building launch capability when the runway is limited and the stakes are high.

• Building launch capability under pressure with limited pre-market runway

• Scaling people, process and go-to-market models after approval

• Aligning commercial, medical and access around a high-complexity launch

• Creating accountability when roles, ownership and infrastructure are still evolving

Pharma Launch Excellence Summit Conference Day 2: Thursday October 1

11:00 AM Panel Discussion: Cell & Gene Therapy Launch: When Every Move Matters

Advanced therapies introduce new challenges across supply, delivery and access, requiring highly coordinated and specialized launch models. In this session, the speaker will delve into:

• Managing manufacturing, logistics and treatment delivery constraints

• Coordinating specialized centres and treatment pathways

• Aligning pricing, access and long-term value

Check out the incredible speaker line-up to see who will be joining Rich.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk